SIGA

SIGA Technologies, Inc. is a healthcare company operating in the specialty and generic drug manufacturers sector. With a market capitalization of $457.60 million, revenue of $172.25 million, and approximately 46 employees, the company has established itself within its industry. The financial health of SIGA is characterized by a gross margin of 65.7%, indicating a moderate level of profitability in its product sales. However, the operating margin stands at -390.2%, suggesting significant expenses or losses that offset revenue. The company's net income and EBITDA are substantial, with $74.47 million and $90.83 million respectively, while free cash flow amounts to $88.44 million. Cash reserves total $171.96 million, whereas debt is minimal at $914,548. Valuation metrics indicate a relatively low price-to-earnings ratio of 6.09 (TTM) and 4.23 (forward), suggesting that the company's current stock price may be considered undervalued by some investors. Revenue growth has been negative over the past year, with a decline of -73.8%. The return on equity stands at 39.9% and the debt-to-equity ratio is 0.45, indicating manageable leverage.